Pfizer Says Third COVID Vaccine Dose Effective Against Omicron Variant
A new study by Pfizer-BioNTech found that a third dose of their COVID-19 vaccine is effective against the emerging omicron variant. The pharmaceutical giants also look to manufacture a vaccine specific to the omicron variant by March 2022.
Orangetheory Brand President Lauren Cody on the fitness industry's shift from chasing aesthetics to prioritizing longevity and measurable health and wellness.
Peachtree Group CEO Greg Friedman breaks down the Fed's rate decision and the Senate's housing affordability bill and what it means for commercial real estate.
Nodi is giving kids a safe way to stay connected before they're ready for a smartphone. CEO Pascal Leonard Blum breaks down how the device works for families.
From coast to coast, gas prices are telling different stories. AAA's Aixa Diaz explains what's behind the numbers and what it means for American drivers.